Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» liver cancer
liver cancer
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
CP Wire
Wed, 09/5/18 - 10:15 am
China
Eisai
Merck
Lenvima
liver cancer
HCC
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
Wed, 09/5/18 - 09:25 am
Eisai
Merck
Lenvima
liver cancer
hepatocellular carcinoma
Death rate from liver cancer skyrockets
WWSB
Fri, 08/17/18 - 09:18 pm
liver cancer
CDC
Japan's Eisai sets price tag of about $16,000 on liver cancer drug
Yahoo/Reuters
Thu, 08/16/18 - 11:12 pm
Eisai
liver cancer
drug pricing
Lenvima
FDA stalls Eisai—and its new partner Merck—in quest to widen cancer med Lenvima's reach
Fierce Pharma
Fri, 05/25/18 - 12:15 pm
Merck
Eisai
Lenvima
liver cancer
FDA
Lilly's Cyramza succeeds in late-stage liver cancer trial
Yahoo/Reuters
Wed, 04/4/18 - 08:55 am
Eli Lilly
Cyramza
liver cancer
clinical trials
Bristol-Myers' I-O star Opdivo steps up to challenge Bayer's Stivarga in liver cancer
Fierce Pharma
Mon, 09/25/17 - 11:04 am
Bristol-Myers Squibb
Opdivo
Bayer
Stivarga
liver cancer
Eisai's Lenvima nabs survival edge in liver cancer showdown with Bayer's Nexavar
Fierce Pharma
Sun, 06/4/17 - 11:51 am
Eisai
Lenvima
liver cancer
Bayer
Nexavar
ASCO 2017
Bayer's Stivarga Shows Slim Progress Against Liver Cancer
Forbes
Thu, 04/27/17 - 05:52 pm
Bayer
Stivarga
liver cancer
Daiichi, ArQule cancer drug fails in late-stage study
BioPharma Dive
Sat, 02/18/17 - 02:43 pm
Daiichi Sankyo
Arqule
clinical trials
tivantinib
liver cancer
Bayer growth hope Stivarga boosts survival in liver cancer patients
Fierce Pharma
Wed, 06/29/16 - 10:50 am
Bayer
Stivarga
liver cancer
Nexavar
hepatocellular carcinoma
Bayer's Stivarga shows efficacy in liver cancer
BioPharma Dive
Thu, 05/5/16 - 02:01 pm
Bayer
Stivarga
liver cancer
FDA Grants Fast Track Designation to Can-Fite's CF102 in the Treatment of Liver Cancer
Yahoo
Thu, 09/17/15 - 09:59 am
Can-Fite BioPharma
CF102
FDA
fast track
hepatocellular carcinoma
liver cancer
Can-Fite's Phase II Liver Cancer Trial Approved in Europe
Yahoo
Mon, 05/11/15 - 09:20 am
Can-Fite BioPharma
liver cancer
CF102
Chinese FDA approves DC Bead for liver cancer treatment
PharmaBiz
Sat, 08/30/14 - 11:05 am
China
DC Bead
SciClone Pharmaceuticals
liver cancer
Lilly's Cyramza fails in liver cancer trial
Yahoo/Reuters
Wed, 06/11/14 - 10:20 am
Eli Lilly
Cyramza
liver cancer
Oncolytics Biotech reports evaluation of clinical study with REOLYSIN
The Fly on the Wall
Mon, 04/14/14 - 08:26 am
Oncolytics
Reolysin
hepatitis B
hepatitis C
liver cancer
Bayer, Onyx Report Primary Endpoint of Phase 3 Study Results of NEXAVAR as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation was Not Met
Bloomberg
Tue, 03/11/14 - 08:22 am
Bayer
ONYX Pharmaceuticals
Nexavar
liver cancer
Biostar Pharmaceuticals to develop liver cancer drug with Chinese university
Yahoo/Fly on the Wall
Thu, 03/6/14 - 10:10 am
Biostar Pharmaceuticals
liver cancer
Celsion Announces FDA Clearance of the OPTIMA Study - A Pivotal Phase III Trial of ThermoDox in Primary Liver Cancer
Yahoo
Mon, 02/24/14 - 11:16 am
FDA
Celsion
liver cancer
ThermoDox
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »